Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance.

Wight JC, Yue M, Keane C, Johnston A, Linton K, Chin C, Wai SH, Talaulikar D, Gasiorowski R, Cheah CY, Gregory GP, Dickinson M, Minson A, Coombes C, Ku M, Lam S, Hawkes EA.

Br J Haematol. 2019 Oct;187(2):174-184. doi: 10.1111/bjh.16064. Epub 2019 Jun 24.

PMID:
31236941
2.

The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.

Minson AG, Cummins K, Fox L, Costello B, Yeung D, Cleary R, Forsyth C, Tatarczuch M, Burbury K, Motorna O, Shortt J, Fleming S, McQuillan A, Schwarer A, Harrup R, Holmes A, Ratnasingam S, Chan KL, Hsu WH, Ashraf A, Putt F, Grigg A.

Blood Adv. 2019 Apr 9;3(7):1084-1091. doi: 10.1182/bloodadvances.2018028035.

3.

Bi-Allelic Mutations in STXBP2 Reveal a Complementary Role for STXBP1 in Cytotoxic Lymphocyte Killing.

Lopez JA, Noori T, Minson A, Li Jovanoska L, Thia K, Hildebrand MS, Akhlaghi H, Darcy PK, Kershaw MH, Brown NJ, Grigg A, Trapani JA, Voskoboinik I.

Front Immunol. 2018 Mar 15;9:529. doi: 10.3389/fimmu.2018.00529. eCollection 2018.

4.

Low dose PD-1 inhibition in relapsed refractory Hodgkin lymphoma after allogeneic stem cell transplant with concomitant active GVHD.

Minson A, Douglas G, Bilmon I, Grigg A.

Br J Haematol. 2019 Mar;184(5):840-844. doi: 10.1111/bjh.15186. Epub 2018 Mar 13. No abstract available.

PMID:
29532918
5.

A comparison of therapeutic hypothermia and strict therapeutic normothermia after cardiac arrest.

Casamento A, Minson A, Radford S, MÃ¥rtensson J, Ridgeon E, Young P, Bellomo R.

Resuscitation. 2016 Sep;106:83-8. doi: 10.1016/j.resuscitation.2016.06.019. Epub 2016 Jun 25.

PMID:
27350372
6.

The order Herpesvirales.

Davison AJ, Eberle R, Ehlers B, Hayward GS, McGeoch DJ, Minson AC, Pellett PE, Roizman B, Studdert MJ, Thiry E.

Arch Virol. 2009;154(1):171-7. doi: 10.1007/s00705-008-0278-4. Epub 2008 Dec 9.

7.

Scaffolds for protein crystallisation.

Stura EA, Taussig MJ, Sutton BJ, Duquerroy S, Bressanelli S, Minson AC, Rey FA.

Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 1):1715-21. Epub 2002 Sep 26.

PMID:
12351893
8.
9.

The herpes simplex virus type 1 Fc receptor discriminates between IgG1 allotypes.

Atherton A, Armour KL, Bell S, Minson AC, Clark MR.

Eur J Immunol. 2000 Sep;30(9):2540-7.

10.

A broad spectrum secreted chemokine binding protein encoded by a herpesvirus.

Parry CM, Simas JP, Smith VP, Stewart CA, Minson AC, Efstathiou S, Alcami A.

J Exp Med. 2000 Feb 7;191(3):573-8.

11.

A study of primary neuronal infection by mutants of herpes simplex virus type 1 lacking dispensable and non-dispensable glycoproteins.

Babic N, Rodger G, Arthur J, Minson AC.

J Gen Virol. 1999 Sep;80 ( Pt 9):2403-2409. doi: 10.1099/0022-1317-80-9-2403.

PMID:
10501494
12.
13.

In vivo complementation studies of a glycoprotein H-deleted herpes simplex virus-based vector.

Speck PG, Efstathiou S, Minson AC.

J Gen Virol. 1996 Oct;77 ( Pt 10):2563-8.

PMID:
8887491
14.

Herpes virus-based vectors.

Efstathiou S, Minson AC.

Br Med Bull. 1995 Jan;51(1):45-55. Review.

PMID:
7767648
15.

Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1.

McLean CS, Erturk M, Jennings R, Challanain DN, Minson AC, Duncan I, Boursnell ME, Inglis SC.

J Infect Dis. 1994 Nov;170(5):1100-9.

PMID:
7963701
16.
17.

Interactions of herpes simplex viruses with the host cell.

Minson AC.

Biochem Soc Trans. 1994 May;22(2):298-301. Review. No abstract available.

PMID:
7958311
18.

Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted.

Farrell HE, McLean CS, Harley C, Efstathiou S, Inglis S, Minson AC.

J Virol. 1994 Feb;68(2):927-32.

19.

Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product.

Kaye JF, Gompels UA, Minson AC.

J Gen Virol. 1992 Oct;73 ( Pt 10):2693-8.

PMID:
1328481
20.

Conservation of HPV-16 E6/E7 ORF sequences in a cervical carcinoma.

Cone RW, Minson AC, Smith MR, McDougall JK.

J Med Virol. 1992 Jun;37(2):99-107.

PMID:
1321227
21.

A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH.

Hutchinson L, Browne H, Wargent V, Davis-Poynter N, Primorac S, Goldsmith K, Minson AC, Johnson DC.

J Virol. 1992 Apr;66(4):2240-50.

22.

The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses.

Roizmann B, Desrosiers RC, Fleckenstein B, Lopez C, Minson AC, Studdert MJ.

Arch Virol. 1992;123(3-4):425-49. Review. No abstract available.

PMID:
1562239
23.
24.

Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.

Forrester AJ, Sullivan V, Simmons A, Blacklaws BA, Smith GL, Nash AA, Minson AC.

J Gen Virol. 1991 Feb;72 ( Pt 2):369-75.

PMID:
1704412
25.

Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants.

Blacklaws BA, Krishna S, Minson AC, Nash AA.

Virology. 1990 Aug;177(2):727-36.

PMID:
2164732
26.

Cloning and molecular characterization of the murine herpesvirus 68 genome.

Efstathiou S, Ho YM, Minson AC.

J Gen Virol. 1990 Jun;71 ( Pt 6):1355-64.

PMID:
2351958
27.

Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus.

McLean CS, Churcher MJ, Meinke J, Smith GL, Higgins G, Stanley M, Minson AC.

J Clin Pathol. 1990 Jun;43(6):488-92.

29.

Properties of a non-tumorigenic human cervical keratinocyte cell line.

Stanley MA, Browne HM, Appleby M, Minson AC.

Int J Cancer. 1989 Apr 15;43(4):672-6.

PMID:
2467886
30.

The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.

Efstathiou S, Kemp S, Darby G, Minson AC.

J Gen Virol. 1989 Apr;70 ( Pt 4):869-79.

PMID:
2543763
31.

Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutants.

Muggeridge MI, Isola VJ, Byrn RA, Tucker TJ, Minson AC, Glorioso JC, Cohen GH, Eisenberg RJ.

J Virol. 1988 Sep;62(9):3274-80.

32.

Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant.

Browne HM, Churcher MJ, Stanley MA, Smith GL, Minson AC.

J Gen Virol. 1988 Jun;69 ( Pt 6):1263-73.

PMID:
2838573
34.

Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.

Cranage MP, Kouzarides T, Bankier AT, Satchwell S, Weston K, Tomlinson P, Barrell B, Hart H, Bell SE, Minson AC, et al.

EMBO J. 1986 Nov;5(11):3057-63.

35.

The properties and sequence of glycoprotein H of herpes simplex virus type 1.

Gompels U, Minson A.

Virology. 1986 Sep;153(2):230-47.

PMID:
3016991
36.
37.
38.

Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it.

Richman DD, Buckmaster A, Bell S, Hodgman C, Minson AC.

J Virol. 1986 Feb;57(2):647-55.

39.

Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans.

Efstathiou S, Minson AC, Field HJ, Anderson JR, Wildy P.

J Virol. 1986 Feb;57(2):446-55.

40.

Diagnosis of human parvovirus infection by dot-blot hybridization using cloned viral DNA.

Anderson MJ, Jones SE, Minson AC.

J Med Virol. 1985 Feb;15(2):163-72.

PMID:
2983011
41.
42.

Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2.

Marsden HS, Buckmaster A, Palfreyman JW, Hope RG, Minson AC.

J Virol. 1984 May;50(2):547-54.

43.
44.

Herpes simplex virus non-structural proteins. III. Function of the major DNA-binding protein.

Littler E, Purifoy D, Minson A, Powell KL.

J Gen Virol. 1983 May;64(Pt 5):983-95.

PMID:
6302216
45.

The state of the herpes genome.

Minson AC.

Nature. 1983 Apr 7;302(5908):477. No abstract available.

PMID:
6300685
46.

The use of monoclonal antibodies in (reverse) passive haemagglutination tests for herpes simplex virus antigens and antibodies.

Cranage MP, McLean CS, Buckmaster EA, Minson AC, Wildy P, Coombs RR.

J Med Virol. 1983;11(4):295-306.

PMID:
6308140
47.

Monoclonal antibodies to three non-glycosylated antigens of herpes simplex virus type 2.

McLean C, Buckmaster A, Hancock D, Buchan A, Fuller A, Minson A.

J Gen Virol. 1982 Dec;63(2):297-305. No abstract available.

PMID:
6296279
49.

Hybridization techniques.

Minson AC, Darby G.

Lab Res Methods Biol Med. 1982;5:185-229. Review. No abstract available.

PMID:
6176828

Supplemental Content

Loading ...
Support Center